Published on: 16th April, 2025 The Central Drugs Standard Control Organization (CDSCO) has released a crucial directive dated 11th April, 2025, addressing the unauthorized manufacture and marketing of Fixed Dose Combinations (FDCs) by pharmaceutical manufacturers in India. The notification highlights…


26 February, 2025 The Central Drugs Standard Control Organization (CDSCO) has issued a circular dated 24.02.2025 for all the manufacturers of Category D Fixed Dose Combinations (FDCs). CDSCO has previously provided two separate pathways for the approvals of Category D…

25th February,2025 The pharmaceutical industry operates under strict regulations to ensure the safety, efficacy, and quality of drugs available in the market. One of the critical aspects of drug classification in India is the definition of a "New Drug" under…
Recent Post
- π¨ CDSCO Issues Urgent Directive for Stopping manufacturing and marketed of Unapproved FDCs β What Pharma Manufacturers Need to Know
- π Unlocking Opportunity: Comprehensive Market Research Reports Now Available at Vaayath Consulting
- πEase of Doing Business: CDSCO introduces new Updates regarding the Auto-generated Market standard Certificate (MSC) and Non-Conviction Certificate (NCC) for Licenced Medical devices.
- Complete List of Banned Drugs in India
- Government Mandates Online CRO Registration via SUGAM Portal!